Moderna Inc. stock falls Monday, underperforms market

© Terrence Horan


Shares of Moderna Inc. MRNA shed 1.19% to $155.07 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.50% to 12,440.04 and the Dow Jones Industrial Average DJIA falling 0.62% to 29,861.55. Moderna Inc. closed $23.43 short of its 52-week high ($178.50), which the company reached on December 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. ABBV fell 2.01% to $104.20, Amgen Inc. AMGN rose 0.91% to $229.46, and AstraZeneca PLC ADR AZN fell 7.81% to $50.03. Trading volume (22.3 M) eclipsed its 50-day average volume of 18.9 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading